Ghent University Academic Bibliography

Advanced

Preliminary evidence for a retardation of structural damage in patients with ankylosing spondylitis continuously treated with infliximab for 4 years

Filip Van Den Bosch, MIEKE DEVINCK, Elli Kruithof, Ilse Hoffman, G VERBRUGGEN, Filip De Keyser UGent, Herman Mielants UGent and Eric Veys (2005) ARTHRITIS AND RHEUMATISM. 52(9).
Please use this url to cite or link to this publication:
author
organization
year
type
conference
publication status
published
subject
in
ARTHRITIS AND RHEUMATISM
Arthritis Rheum.
volume
52
issue
9
pages
S635-S635 pages
publisher
WILEY-LISS
Web of Science type
Meeting Abstract
Web of Science id
000232207803256
JCR category
RHEUMATOLOGY
JCR impact factor
7.421 (2005)
JCR rank
1/22 (2005)
JCR quartile
1 (2005)
ISSN
0004-3591
language
English
UGent publication?
yes
classification
C3
id
350573
handle
http://hdl.handle.net/1854/LU-350573
date created
2006-04-07 15:55:00
date last changed
2008-06-13 10:59:53
@inproceedings{350573,
  author       = {Van Den Bosch, Filip and DEVINCK, MIEKE and Kruithof, Elli and Hoffman, Ilse and VERBRUGGEN, G and De Keyser, Filip and Mielants, Herman and Veys, Eric},
  booktitle    = {ARTHRITIS AND RHEUMATISM},
  issn         = {0004-3591},
  language     = {eng},
  number       = {9},
  pages        = {S635-S635},
  publisher    = {WILEY-LISS},
  title        = {Preliminary evidence for a retardation of structural damage in patients with ankylosing spondylitis continuously treated with infliximab for 4 years},
  volume       = {52},
  year         = {2005},
}

Chicago
Van Den Bosch, Filip, MIEKE DEVINCK, Elli Kruithof, Ilse Hoffman, G VERBRUGGEN, Filip De Keyser, Herman Mielants, and Eric Veys. 2005. “Preliminary Evidence for a Retardation of Structural Damage in Patients with Ankylosing Spondylitis Continuously Treated with Infliximab for 4 Years.” In Arthritis and Rheumatism, 52:635. WILEY-LISS.
APA
Van Den Bosch, F., DEVINCK, M., Kruithof, E., Hoffman, I., VERBRUGGEN, G., De Keyser, F., Mielants, H., et al. (2005). Preliminary evidence for a retardation of structural damage in patients with ankylosing spondylitis continuously treated with infliximab for 4 years. ARTHRITIS AND RHEUMATISM (Vol. 52, p. 635). WILEY-LISS.
Vancouver
1.
Van Den Bosch F, DEVINCK M, Kruithof E, Hoffman I, VERBRUGGEN G, De Keyser F, et al. Preliminary evidence for a retardation of structural damage in patients with ankylosing spondylitis continuously treated with infliximab for 4 years. ARTHRITIS AND RHEUMATISM. WILEY-LISS; 2005. p. 635.
MLA
Van Den Bosch, Filip, MIEKE DEVINCK, Elli Kruithof, et al. “Preliminary Evidence for a Retardation of Structural Damage in Patients with Ankylosing Spondylitis Continuously Treated with Infliximab for 4 Years.” Arthritis and Rheumatism. Vol. 52. WILEY-LISS, 2005. 635. Print.